Adenosine receptor activation modulates intraocular pressure in rabbits

Crosson, C.E.

Journal of Pharmacology and Experimental Therapeutics 273(1): 320-326

1995


ISSN/ISBN: 0022-3565
PMID: 7714784
Document Number: 440002
The relatively selective adenosine A-1 agonists N-6-cyclohexyladenosine (CHA), R(-)-N-6-(2-phenylisopropyl)adenosine (RPIA) and S(+)-N-6-(2-phenylisopropyl)adenosine (S-PIA); the A-2a agonist 2-p-(2-carboxyethyl)phenethyl-amino-5'-N-ethylcarboxamidoadenosine (CGS-21680) and the nonselective A-2 agonist 2-phenylaminoadenosine (CV-1808) were evaluated in vivo for their effects on aqueous humor dynamics and in vitro for their action on 3H-norepinephrine release and cAMP accumulation in the isolated iris/ciliary body. These studies demonstrated that adenosine agonists can modulate intraocular pressure (IOP). Except for CV-1808, the topical administration of adenosine agonists produced a unilateral dose-related reduction in IOP with a potency order of R-PIA = CHA gt CGS-21680 gt S-PIA gt CV-1808. Although CV-1808 did not lower IOP, it did induce a significant dose-dependent rise in IOP. Neither the reduction in IOP induced by R-PIA nor the rise in IOP induced by CV-1808 was affected by surgical removal of the superior cervical ganglion. However, the adenosine agonist-induced reduction in IOP was associated with a significant decrease in aqueous flow. In vitro studies demonstrated that the adenosine agonists did not alter the evoked release of 3H-norepinephrine; however, they were effective in suppressing the accumulation of cAMP, and this response was blocked by pretreatment with the antagonist 8-cyclopentyl-1,3-dimethylxanthine. These studies provide evidence that adenosine agonists lower IOP by activating postjunctional adenosine A-1 receptors. This response is associated with a reduction in aqueous flow and the modulation of cAMP in the iris/ciliary body. Although the CV-1808-induced rise in IOP also appears to result from the activation of adenosine receptors, determination of the receptor subtype and mechanism of action involved in this response requires additional investigation.

Document emailed within 1 workday
Secure & encrypted payments